Apple avoids a second import ban for its redesigned smartwatches in latest court ruling

The US International Trade Commission has ruled against reinstating an import ban on Apple Watches, allowing Apple to continue selling its devices with a reworked blood-oxygen monitoring technology. The ITC terminated the case, citing a preliminary ruling that Apple's redesigned smartwatches don't infringe on Masimo's patents. The patent battle between Masimo and Apple dates back to 2021, when Masimo first filed against Apple. Apple redesigned the blood-oxygen reading feature in certain models after the ITC initially ruled that Apple violated Masimo's patents. Masimo may appeal the decision with the US Court of Appeals for the Federal Circuit. Apple was also recently ruled to pay $634 million in a separate patent infringement case.